Related Experiment Video

Updated: Jun 5, 2026

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice
07:35

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Published on: January 26, 2024

Acute consequences of hypoglycaemia in diabetic patients

S Halimi1

  • 1Clinique d'Endocrinologie Diabétologie Nutrition, Pôle DigiDUNE, CHU Grenoble, BP217X, Grenoble, France. shalimi@chu-grenoble.fr

Diabetes & Metabolism
|January 8, 2011
PubMed

Insights

Hypoglycaemia, or low blood sugar, is a significant concern for diabetes patients, potentially leading to serious cardiovascular events and cognitive decline. Re-evaluating treatment targets and using safer medications are crucial for prevention.

Area of Science:

  • Endocrinology
  • Cardiology
  • Neurology

Background:

  • Strict glycaemic control is a primary goal in diabetes management.
  • Hypoglycaemia is a major limiting factor, with acute consequences often underestimated.
  • Recent trials question the mortality benefits of intensive glycaemic control due to increased severe hypoglycaemia and cardiovascular deaths.

Purpose of the Study:

  • To evaluate the acute consequences of hypoglycaemic attacks in diabetic patients.
  • To assess the potential link between hypoglycaemia and cardiovascular complications.
  • To highlight neurological and cognitive impacts, particularly in older adults.

Main Methods:

  • Review of recent large clinical trials in type 2 diabetes.
  • Analysis of reported adverse events, including cardiovascular and neurological complications.
  • Discussion of potential mechanisms linking hypoglycaemia to adverse outcomes.

Main Results:

  • Intensive glycaemic control arms showed higher rates of severe hypoglycaemia and excess cardiovascular deaths.
  • Hypoglycaemia can precipitate "dead in bed" syndrome in type 1 diabetics (arrhythmia, prolonged QTc).
  • Neurologic syndromes are common but usually reversible; cognitive defects/dementia may be underestimated in older type 2 diabetics.

Conclusions:

  • Iatrogenic hypoglycaemia from insulin or sulfonylureas causes recurrent morbidity in type 1 and type 2 diabetes.
  • Prevention strategies include re-evaluating glycaemic targets, patient education, and utilizing new antidiabetic drugs with lower hypoglycaemic risk.

More Related Videos

Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Related Concept Videos

Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...